Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®

J Clin Densitom. 2011 Jul-Sep;14(3):190-3. doi: 10.1016/j.jocd.2011.05.011.

Abstract

The worldwide prevalence of smoking has been estimated at about 50% in men, and 10% in women, with larger variations among different populations studied. Smoking has been shown to affect many organ systems resulting in severe morbidity and increased mortality. In addition, smoking has been identified as a predictor of ten-year fracture risk in men and women, largely independent of an individual's bone mineral density. This finding has eventually lead to incorporation of this risk factor into FRAX®, an algorithm that has been developed to calculate an individual's ten-year fracture risk. However, only little, or conflicting data is available on a possible association between smoking dose, duration, length of time after cessation, type of tobacco and fracture risk, limiting this risk factor's applicability in the context of FRAX®.

Publication types

  • Consensus Development Conference

MeSH terms

  • Absorptiometry, Photon
  • Algorithms
  • Diagnosis, Computer-Assisted*
  • Female
  • Fractures, Bone / diagnosis*
  • Fractures, Bone / etiology
  • Humans
  • Male
  • Models, Statistical
  • Osteoporotic Fractures / diagnosis
  • Osteoporotic Fractures / etiology
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects*
  • Smoking Cessation